Trial
NCT05879185
A Study of XmAb23104 in People With Sarcoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Xencor, Inc.
Condition
Sarcoma
Intervention
XmAb23104
Why stopped
Vendor decided study to be closed early
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13